Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs

House Oversight Committee report combats industry claims that lower drug prices would stifle innovation.


TAP depends on your support

We’ve said it before: The greatest threat to democracy from the media isn’t disinformation, it’s the paywall. When you support The American Prospect, you’re supporting fellow readers who aren’t able to give, and countering the class system for information. Please, become a member, or make a one-time donation, today. Thank you!